<DOC>
	<DOCNO>NCT02982200</DOCNO>
	<brief_summary>A global prospective , multi-center , single-arm , post-market clinical follow-up ( PMCF ) study conduct assess performance Medina Embolization Device use unruptured ruptured intracranial aneurysm .</brief_summary>
	<brief_title>Medina Embolization Device In Neurovascular Aneurysm Study</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Subject provide write informed consent use Ethics Committeeapproved consent form agree comply protocol requirement Subject 18 85 year old Subject rupture unruptured saccular intracranial aneurysm amenable treat Medina Embolization Device Aneurysm partially thrombose Aneurysm previously treat surgery endovascular therapy Subject major brain surgery include endovascular procedure within past 30 day Vessel characteristic ( tortuosity , stenosis , morphology ) preclude safe endovascular access aneurysm Subject pregnant breastfeeding wish become pregnant length study participation The Investigator determines validity study outcome may compromise subject 's enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Embolization Device</keyword>
	<keyword>Medina</keyword>
	<keyword>Rupture Intracranial Aneurysm</keyword>
	<keyword>Unrupture Intracranial Aneurysm</keyword>
</DOC>